Literature DB >> 15537875

Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice.

Yona Goldshmit1, Mary P Galea, Graham Wise, Perry F Bartlett, Ann M Turnley.   

Abstract

Spinal cord injury usually results in permanent paralysis because of lack of regrowth of damaged neurons. Here we demonstrate that adult mice lacking EphA4 (-/-), a molecule essential for correct guidance of spinal cord axons during development, exhibit axonal regeneration and functional recovery after spinal cord hemisection. Anterograde and retrograde tracing showed that axons from multiple pathways, including corticospinal and rubrospinal tracts, crossed the lesion site. EphA4-/- mice recovered stride length, the ability to walk on and climb a grid, and the ability to grasp with the affected hindpaw within 1-3 months of injury. EphA4 expression was upregulated on astrocytes at the lesion site in wild-type mice, whereas astrocytic gliosis and the glial scar were greatly reduced in lesioned EphA4-/- spinal cords. EphA4-/- astrocytes failed to respond to the inflammatory cytokines, interferon-gamma or leukemia inhibitory factor, in vitro. Neurons grown on wild-type astrocytes extended shorter neurites than on EphA4-/- astrocytes, but longer neurites when the astrocyte EphA4 was blocked by monomeric EphrinA5-Fc. Thus, EphA4 regulates two important features of spinal cord injury, axonal inhibition, and astrocytic gliosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537875      PMCID: PMC6730186          DOI: 10.1523/JNEUROSCI.2981-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  110 in total

1.  Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment.

Authors:  Yimin Yuan; Zhida Su; Yingyan Pu; Xiujie Liu; Jingjing Chen; Feng Zhu; Yanling Zhu; Han Zhang; Cheng He
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury.

Authors:  Philip Duffy; Xingxing Wang; Chad S Siegel; Chad S Seigel; Nathan Tu; Mark Henkemeyer; William B J Cafferty; Stephen M Strittmatter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 3.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

4.  Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling.

Authors:  Fardad T Afshari; Jessica C Kwok; James W Fawcett
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 5.  Unravelling the development of the visual cortex: implications for plasticity and repair.

Authors:  James A Bourne
Journal:  J Anat       Date:  2010-08-17       Impact factor: 2.610

Review 6.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 7.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

8.  Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Authors:  Jung-Yu C Hsu; Lilly Y W Bourguignon; Christen M Adams; Karine Peyrollier; Haoqian Zhang; Thomas Fandel; Christine L Cun; Zena Werb; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

9.  Use of polysialic acid in repair of the central nervous system.

Authors:  Abderrahman El Maarouf; Athanasios K Petridis; Urs Rutishauser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

10.  Generation of an EphA4 conditional allele in mice.

Authors:  Julia E Herrmann; Morgan A Pence; Emanuel A Shapera; Ravi R Shah; Cédric G Geoffroy; Binhai Zheng
Journal:  Genesis       Date:  2010-02       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.